GTC Biotherapeutics Inc
(NASDAQ:GTCB)|
0.13 0.00 (0.00%) Dec 04 - Close |
|
|
|
After-Hours 0.14 +0.01 (7.69%) Thu, 4 Dec 2008 7:40 PM
- Compare GTCB with:
- View: Line | Candlestick
Company Profile
GTC Biotherapeutics Inc
175 Crossing Boulevard
Framingham, MA 01702
United States - Map
Phone: (508) 620-9700
Fax: (508) 370-3797
Website: www.gtc-bio.com
State of incorporation: Massachusetts
CEO: Dr. Geoffrey F. Cox, Ph.D.
Employees: 167
Sector: Healthcare
Industry Group: Drugs
Industry: Biotechnology
Dev/prod recombinant proteins for therapeutic uses
The Company is engaged in the development and production of human therapeutic proteins through transgenic technology.
Recent news for GTCB
-
EDGAR Online - Nov 12 at 7:05 ET
-
GTC Biotherapeutics Receives NASDAQ Notice
Business Wire - Nov 11 at 7:00 ET
-
GTC BIOTHERAPEUTICS INC Financials
EDGAR Online Financials - Nov 08 at 9:04 ET
-
EDGAR Online - Nov 06 at 4:35 ET
-
Business Wire - Nov 05 at 9:10 ET
-
GTC BIOTHERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
EDGAR Online - Nov 04 at 4:17 ET
-
New Star Analyst Rankings for GTC BIOTHERAP INC
StarMine - Nov 04 at 9:24 ET
-
GTC Biotherapeutics, Inc. Earnings Call scheduled for 10:00 am ET today
CCBN - Nov 03 at 10:00 ET
-
EDGAR Online - Nov 03 at 9:06 ET
-
GTC Biotherapeutics Reports Third Quarter 2008 Financial Results
Business Wire - Nov 03 at 8:00 ET